CYP 2.50% 19.5¢ cynata therapeutics limited

Ann: Ethics Approval to Commence Clinical Trial in COVID-19, page-274

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Some news items on the ongoing effects of this virus....

    ‘The range of lingering health effects for those that contract COVID-19 and survive remains to be seen.’

    https://www.marketwatch.com/story/another-warning-from-1918-spanish-flu-for-covid-19-survival-does-not-mean-that-individuals-fully-recovered-2020-08-18?mod=mw_more_headlines


    In a study published in the European Respiratory Journal on Wednesday, the researchers found extremely high levels of “angiotensin converting enzyme II,” or ACE-2, only in the area of the nose responsible for smelling. The ACE-2 enzyme is thought to be the gateway that allows coronavirus to enter the cells of the body and cause an infection.

    https://www.marketwatch.com/story/johns-hopkins-scientists-examining-weird-side-effects-of-covid-19-say-this-could-be-how-virus-gains-a-foothold-in-the-body-2020-08-19?mod=mw_more_headlines





 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.005(2.50%)
Mkt cap ! $35.20M
Open High Low Value Volume
21.0¢ 21.0¢ 19.5¢ $18.97K 94.53K

Buyers (Bids)

No. Vol. Price($)
1 4999 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.